Abstract：
OBJECTIVE: Bipolar disorder (BD) and borderline personality disorder (BPD) are both serious psychiatric conditions that elevate the risk for harmful outcomes. Although these conditions represent distinct diagnostic entities, existing research suggests that approximately 20% of individuals with BD meet the criteria for comorbid BPD. Individuals with comorbid BD/BPD appear to have a markedly more severe and phenomenologically distinct clinical course when compared with those with BD alone. However, treatments have generally not been tested in this specific population, and currently, no formal treatment guidelines exist for this subgroup of patients.
METHODS: In the current paper, we review the epidemiological and descriptive research characterizing those with comorbid BD/BPD and discuss the impact of this comorbidity on psychosocial treatment. We also review current findings on evidence-based treatments for BD and BPD that show promise in treating those with comorbid BD/BPD.
RESULTS: In our review of the literature, we highlight the importance of recognizing this comorbidity and discuss avenues for developing and integrating evidence-based treatment approaches for this understudied clinical population.
CONCLUSIONS: Although formal trials of interventions targeted to comorbid BD/BPD are limited, there is promising evidence regarding the possibility of using or integrating existing evidence-based approaches for this population. There are also several areas of clinical practice improvement and future research directions that stem from this literature.
METHODS: In the current paper, we review the epidemiological and descriptive research characterizing those with comorbid BD/BPD and discuss the impact of this comorbidity on psychosocial treatment. We also review current findings on evidence-based treatments for BD and BPD that show promise in treating those with comorbid BD/BPD.
RESULTS: In our review of the literature, we highlight the importance of recognizing this comorbidity and discuss avenues for developing and integrating evidence-based treatment approaches for this understudied clinical population.
CONCLUSIONS: Although formal trials of interventions targeted to comorbid BD/BPD are limited, there is promising evidence regarding the possibility of using or integrating existing evidence-based approaches for this population. There are also several areas of clinical practice improvement and future research directions that stem from this literature.
摘要：
目的：双相情感障碍（BD）和边缘性人格障碍（BPD）都是严重的精神疾病，会增加有害结果的风险。虽然这些条件代表不同的诊断实体，现有研究表明，约有20％的BD患者符合合并症BPD的标准。与单独患有BD的患者相比，患有BD/BPD合并症的患者的临床病程明显更严重且在现象学上不同。然而,治疗通常没有在这个特定人群中进行测试，目前,本亚组患者尚无正式的治疗指南.
方法：在当前的论文中，我们回顾了BD/BPD合并症患者的流行病学和描述性研究，并讨论了这种合并症对社会心理治疗的影响。我们还回顾了目前关于BD和BPD循证治疗的发现，这些发现显示出有望治疗BD/BPD合并症的患者。
结果：在我们对文献的回顾中，我们强调了认识到这一合并症的重要性,并讨论了为这一尚未得到充分研究的临床人群开发和整合循证治疗方法的途径.
结论：尽管针对BD/BPD共病的干预措施的正式试验有限，有有希望的证据表明，有可能对该人群使用或整合现有的循证方法。也有几个领域的临床实践改进和未来的研究方向源于这些文献。
方法：在当前的论文中，我们回顾了BD/BPD合并症患者的流行病学和描述性研究，并讨论了这种合并症对社会心理治疗的影响。我们还回顾了目前关于BD和BPD循证治疗的发现，这些发现显示出有望治疗BD/BPD合并症的患者。
结果：在我们对文献的回顾中，我们强调了认识到这一合并症的重要性,并讨论了为这一尚未得到充分研究的临床人群开发和整合循证治疗方法的途径.
结论：尽管针对BD/BPD共病的干预措施的正式试验有限，有有希望的证据表明，有可能对该人群使用或整合现有的循证方法。也有几个领域的临床实践改进和未来的研究方向源于这些文献。
